Tranexamic acid: less bleeding and less thrombosis?

The early administration of tranexamic acid (TXA) to bleeding trauma patients reduces all-cause mortality without increasing the risk of vascular occlusive events. Indeed, the risk of arterial thrombosis appears to be reduced with TXA. In this commentary we hypothesize that TXA has an antithrombotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Godier, Anne, Roberts, Ian, Hunt, Beverley J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580652/
https://www.ncbi.nlm.nih.gov/pubmed/22748073
http://dx.doi.org/10.1186/cc11374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580652/
https://www.ncbi.nlm.nih.gov/pubmed/22748073
http://dx.doi.org/10.1186/cc11374

Ejemplares similares